Stocks
Immunome (IMNM) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 3 787% | 1 277% | 17 861% | 9 384% | 12 414% | 7 850% | |||
| Changes by years, y/y, % | +770pp | -2 509pp | +16 583pp | -8 477pp | +3 030pp | +32.7% | |||
Immunome. R&D/CAPEX, %
Immunome. R&D/CAPEX, changes, pp
Immunome (IMNM) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 3 692% | 1 681% | 10 619% | 25 840% | 5 872% | 7 850% | ||
| Changes by years, y/y, % | -130 942pp | -1 682pp | +19 935pp | +2 180pp | ||||
| Changes by quarters, q/q, % | -2 214pp | -2 010pp | +8 938pp | +15 221pp | -19 969pp | |||
